Medicare Considers 340B Drug Cut, AI in Drug Discovery

Medicare is proposing significant payment cuts to the 340B drug discount program, impacting hospitals and clinics that serve low-income populations. Meanwhile, Anthropic's CEO Dario Amodei discussed the potential and limitations of AI in accelerating drug discovery, emphasizing the need for cautious optimism.